Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions

J Ye, L Zheng, Y He, X Qi - MedComm, 2023 - Wiley Online Library
Human papillomavirus (HPV) is the most prevalent sexually transmitted virus globally.
Persistent high‐risk HPV infection can result in cervical precancerous lesions and cervical …

Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research

SJ Lee, A Yang, TC Wu… - Journal of gynecologic …, 2016 - synapse.koreamed.org
Cervical cancer is the fourth most lethal women's cancer worldwide. Current treatments
against cervical cancer include surgery, radiotherapy, chemotherapy, and anti-angiogenic …

Advances in HPV‐associated tumor management: therapeutic strategies and emerging insights

X Gong, H Chi, Z Xia, G Yang… - Journal of Medical …, 2023 - Wiley Online Library
With the rapid increase in the incidence of cervical cancer, anal cancer and other cancers,
human papillomavirus (HPV) infection has become a growing concern. Persistent infection …

Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research

이성종 - Journal of gynecologic oncology, 2016 - dbpia.co.kr
Cervical cancer is the fourth most lethal women's cancer worldwide. Current
treatmentsagainst cervical cancer include surgery, radiotherapy, chemotherapy, and anti …

HPV infection: immunological aspects and their utility in future therapy

E Deligeoroglou, A Giannouli… - … in obstetrics and …, 2013 - Wiley Online Library
High prevalence and mortality rates of cervical cancer create an imperative need to clarify
the uniqueness of HPV (Human Papillomavirus) infection, which serves as the key causative …

Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer

T Sasagawa, H Takagi, S Makinoda - Journal of Infection and …, 2012 - Elsevier
Human papillomavirus (HPV) is the most important etiological factor for cervical cancer. A
recent study demonstrated that more than 20 HPV types were thought to be oncogenic for …

The precision prevention and therapy of HPV‐related cervical cancer: new concepts and clinical implications

Z Hu, D Ma - Cancer medicine, 2018 - Wiley Online Library
Cervical cancer is the third most common cancer in women worldwide, with concepts and
knowledge about its prevention and treatment evolving rapidly. Human papillomavirus …

HPV-mediated cervical cancer: A systematic review on immunological basis, molecular biology, and immune evasion mechanisms

R Vanajothi, N Srikanth, R Vijayakumar… - Current Drug …, 2022 - ingentaconnect.com
Background: Human papillomavirus (HPV), one of the most frequently transmitted viruses,
causes several malignancies, including cervical cancer. Aim: Owing to its unique …

Current Status of Human Papillomavirus–Targeted Therapies Development in Head and Neck Cancer

JC Park, B Bertaux, J Park, S Park - JCO Precision Oncology, 2023 - ascopubs.org
PURPOSE While the incidence of smoking-related head and neck squamous cell carcinoma
(HNSCC) has been declining, that of human papillomavirus (HPV)–mediated HNSCC has …

Targeting HPV in gynaecological cancers–Current status, ongoing challenges and future directions

SM Crusz, K El-Shakankery, RE Miller - Women's Health, 2020 - journals.sagepub.com
Despite the success of preventive vaccination, the Human Papilloma Virus still accounts for
266,000 deaths annually, as the main causative factor of cervical, vaginal, anal, penile and …